Steve N. Leonard

1.2k total citations · 1 hit paper
11 papers, 937 citations indexed

About

Steve N. Leonard is a scholar working on Infectious Diseases, Pharmacology and Molecular Biology. According to data from OpenAlex, Steve N. Leonard has authored 11 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 6 papers in Pharmacology and 5 papers in Molecular Biology. Recurrent topics in Steve N. Leonard's work include Antimicrobial Resistance in Staphylococcus (9 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Bacterial Identification and Susceptibility Testing (5 papers). Steve N. Leonard is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (9 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Bacterial Identification and Susceptibility Testing (5 papers). Steve N. Leonard collaborates with scholars based in United States and Bahrain. Steve N. Leonard's co-authors include Michael J. Rybak, Brian P. Conlon, Vincent M. Isabella, K. Coleman, Joshua Adkins, Kim Lewis, Ernesto Nakayasu, Richard Smith, L Fleck and Michael D. LaFleur and has published in prestigious journals such as Nature, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Steve N. Leonard

11 papers receiving 914 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activated ClpP kills persisters and eradicates a chronic biofilm infection

2013 520 citations Brian P. Conlon, Ernesto Nakayasu et al. Nature profile →

Peers

Steve N. Leonard

ID

MB

CB

MM

PHARM

Silke Besier Germany

Tomomi Hishinuma Japan

Choon Kim United States

Emily K. Crispell United States

Donald Biek United States

Yuh Morimoto Japan

Aileen Rubio United States

Klaudia Kosowska-Shick United States

Céline Vidaillac United States

Intetsu Kobayashi Japan

Silke Besier Germany

Steve N. Leonard

502 ×1.0

ID

436 ×1.0

MB

148 ×0.6

CB

304 ×1.3

MM

100 ×0.6

PHARM

Citations per year, relative to Steve N. Leonard Steve N. Leonard (= 1×) peers Silke Besier

Countries citing papers authored by Steve N. Leonard

Since Specialization

Citations

This map shows the geographic impact of Steve N. Leonard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve N. Leonard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve N. Leonard more than expected).

Fields of papers citing papers by Steve N. Leonard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve N. Leonard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve N. Leonard. The network helps show where Steve N. Leonard may publish in the future.

Co-authorship network of co-authors of Steve N. Leonard

This figure shows the co-authorship network connecting the top 25 collaborators of Steve N. Leonard. A scholar is included among the top collaborators of Steve N. Leonard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve N. Leonard. Steve N. Leonard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Dilworth, Thomas J., Steve N. Leonard, A. Mary Vilay, & Renée-Claude Mercier. (2014). Vancomycin and Piperacillin-Tazobactam Against Methicillin-Resistant Staphylococcus aureus and Vancomycin-Intermediate Staphylococcus aureus in an In Vitro Pharmacokinetic/Pharmacodynamic Model. Clinical Therapeutics. 36(10). 1334–1344. 16 indexed citations

2.

Conlon, Brian P., Ernesto Nakayasu, L Fleck, et al.. (2013). Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature. 503(7476). 365–370. 520 indexed citations breakdown →

3.

Leonard, Steve N., et al.. (2012). Evaluation of the combination of daptomycin and nafcillin against vancomycin-intermediate Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 68(3). 644–647. 19 indexed citations

4.

Vidaillac, Céline, Steve N. Leonard, & Michael J. Rybak. (2010). In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates. International Journal of Antimicrobial Agents. 35(6). 527–530. 19 indexed citations

5.

Leonard, Steve N., et al.. (2009). Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides. Journal of Antimicrobial Chemotherapy. 63(3). 489–492. 63 indexed citations

6.

Vidaillac, Céline, Steve N. Leonard, Hélio S. Sader, Ronald N. Jones, & Michael J. Rybak. (2009). In Vitro Activity of Ceftaroline Alone and in Combination against Clinical Isolates of Resistant Gram-Negative Pathogens, Including β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 53(6). 2360–2366. 42 indexed citations

7.

Vidaillac, Céline, Steve N. Leonard, & Michael J. Rybak. (2009). In Vitro Activity of Ceftaroline against Methicillin-Resistant Staphylococcus aureus and Heterogeneous Vancomycin-Intermediate S. aureus in a Hollow Fiber Model. Antimicrobial Agents and Chemotherapy. 53(11). 4712–4717. 61 indexed citations

8.

Leonard, Steve N. & Michael J. Rybak. (2008). Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations. Journal of Antimicrobial Chemotherapy. 63(1). 155–160. 21 indexed citations

9.

Leonard, Steve N., et al.. (2008). Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 62(6). 1305–1310. 17 indexed citations

10.

Rybak, Michael J., et al.. (2008). Characterization of Vancomycin-Heteroresistant Staphylococcus aureus from the Metropolitan Area of Detroit, Michigan, over a 22-Year Period (1986 to 2007). Journal of Clinical Microbiology. 46(12). 4119–4119. 38 indexed citations

11.

Rybak, Michael J., et al.. (2008). Characterization of Vancomycin-Heteroresistant Staphylococcus aureus from the Metropolitan Area of Detroit, Michigan, over a 22-Year Period (1986 to 2007). Journal of Clinical Microbiology. 46(9). 2950–2954. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact